アバンディア 4mg/8mg
2型糖尿病の原因であるインスリン抵抗性を直接改善することによって、血糖コントロールを助けます。
出荷時点、パッケージの改訂などにより、 左の写真とは外観・カプセルの色が異なることがあります。
The management of antidiabetic therapy should be individualized. Periodic fasting blood glucose measurements should be performed to monitor therapeytic response prior to up-titrating dose. AVANDIA may be taken with or without food.
The usual starting dose of AVANDIA is 4 mg administered either as a single dose once daily or in divided doses twice daily. For patiants who respond inadequately following 12 weeks of treatment as determined by reduction in FPG, the dose may be increased to 8 mg administered as a single dose once daily or in divided doses twice daily. Reductions in glycaemic parameters by dose and regimen are described under Pharmacodynamics and Clinical Effects. In clinical trials, the 4 mg twice daily regimen resulted in the greatest reduction in FPG and HbA1c.